<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>NIZORAL- ketoconazole shampoo </strong><br>Janssen Pharmaceuticals, Inc.<br></p></div>
<h1>Nizoral<span class="Sup">®</span> (ketoconazole) 2% Shampoo</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo is a red-orange liquid for topical application, containing the broad spectrum synthetic antifungal agent ketoconazole in a concentration of 2% in an aqueous suspension. It also contains: coconut fatty acid diethanolamide, disodium monolauryl ether sulfosuccinate, F.D.&amp;C. Red No. 40, hydrochloric acid, imidurea, laurdimonium hydrolyzed animal collagen, macrogol 120 methyl glucose dioleate, perfume bouquet, sodium chloride, sodium hydroxide, sodium lauryl ether sulfate, and purified water.</p>
<p>Ketoconazole is <span class="Underline">cis</span>-1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1<span class="Underline">H</span>-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine and has the following structural formula:</p>
<div class="Figure"><img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=efbc6388-90ce-11de-b92c-8b7156d89593&amp;name=nizoral-shampoo-01.jpg"></div>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">Tinea</span> (pityriasis) versicolor is a non-contagious <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> of the skin caused by <span class="Italics">Pityrosporum orbiculare</span> (<span class="Italics">Malassezia furfur</span>). This commensal organism is part of the normal skin flora. In susceptible individuals the condition is often recurrent and may give rise to hyperpigmented or hypopigmented patches on the trunk which may extend to the neck, arms and upper thighs. Treatment of the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> may not immediately result in restoration of pigment to the affected sites. Normalization of pigment following successful therapy is variable and may take months, depending on individual skin type and incidental skin exposure. The rate of recurrence of <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> is variable.</p>
<p>NIZORAL<span class="Sup">®</span> (ketoconazole) was not detected in plasma in 39 patients who shampooed 4–10 times per week for 6 months, or in 33 patients who shampooed 2–3 times per week for 3–26 months (mean: 16 months).</p>
<p>An exaggerated use washing test on the sensitive antecubital skin of 10 subjects twice daily for five consecutive days showed that the irritancy potential of ketoconazole 2% shampoo was significantly less than that of 2.5% selenium sulfide shampoo.</p>
<p>A human sensitization test, a <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">phototoxicity</span> study, and a photoallergy study conducted in 38 male and 22 female volunteers showed no contact sensitization of the delayed <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> type, no <span class="product-label-link" type="condition" conceptid="4080920" conceptname="Phytophotodermatitis">phototoxicity</span> and no photoallergenic potential due to NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo.</p>
<div class="Section" data-sectionCode="43679-0">
<a name="section-2.1"></a><p></p>
<p class="First"><span class="Bold">Mode of Action:</span> Interpretations of <span class="Italics">in vivo</span> studies suggest that ketoconazole impairs the synthesis of ergosterol, which is a vital component of fungal cell membranes. It is postulated, but not proven, that the therapeutic effect of ketoconazole in <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> (pityriasis) versicolor is due to the reduction of <span class="Italics">Pityrosporum orbiculare</span> (<span class="Italics">Malassezia furfur</span>) and that the therapeutic effect in <span class="product-label-link" type="condition" conceptid="4308080" conceptname="Pityriasis simplex">dandruff</span> is due to the reduction of <span class="Italics">Pityrosporum ovale</span>. Support for the therapeutic effect in <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span> comes from a three-arm, parallel, double-blind, placebo controlled study in patients who had moderately severe <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> (pityriasis) versicolor. Successful response rates in the primary efficacy population for each of both three-day and single-day regimens of ketoconazole 2% shampoo were statistically significantly greater (73% and 69%, respectively) than a placebo regimen (5%). There had been mycological confirmation of fungal disease in all cases at baseline. Mycological clearing rates were 84% and 78%, respectively, for the three-day and one-day regimens of the 2% shampoo and 11% in the placebo regimen. While the differences in the rates of successful response between either of the two active treatments and placebo were statistically significant, the difference between the two active regimens was not.</p>
</div>
<div class="Section" data-sectionCode="49489-8">
<a name="section-2.2"></a><p></p>
<p class="First"><span class="Bold">Microbiology:</span> NIZORAL<span class="Sup">®</span> (ketoconazole) is a broad spectrum synthetic antifungal agent which inhibits the growth of the following common dermatophytes and yeasts by altering the permeability of the cell membrane: dermatophytes: <span class="Italics">Trichophyton rubrum</span>, <span class="Italics">T. mentagrophytes</span>, <span class="Italics">T. tonsurans</span>, <span class="Italics">Microsporum canis</span>, <span class="Italics">M. audouini</span>, <span class="Italics">M. gypseum</span> and <span class="Italics">Epidermophyton floccosum</span>; yeasts: <span class="Italics"><span class="product-label-link" type="condition" conceptid="433968" conceptname="Candidiasis">Candida</span> albicans</span>, <span class="Italics">C. tropicalis</span>, <span class="Italics">Pityrosporum ovale</span> (<span class="Italics">Malassezia ovale</span>) and <span class="Italics">Pityrosporum orbiculare</span> (<span class="Italics">M. furfur</span>). Development of resistance by these microorganisms to ketoconazole has not been reported.</p>
</div>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo is indicated for the treatment of <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">tinea</span> (pityriasis) versicolor caused by or presumed to be caused by <span class="Italics">Pityrosporum orbiculare</span> (also known as <span class="Italics">Malassezia furfur</span> or <span class="Italics">M. orbiculare</span>).</p>
<p>Note: <span class="product-label-link" type="condition" conceptid="135473" conceptname="Dermatophytosis">Tinea</span> (pityriasis) versicolor may give rise to hyperpigmented or hypopigmented patches on the trunk which may extend to the neck, arms and upper thighs. Treatment of the <span class="product-label-link" type="condition" conceptid="432250" conceptname="Infectious disease">infection</span> may not immediately result in normalization of pigment to the affected sites. Normalization of pigment following successful therapy is variable and may take months, depending on individual skin type and incidental sun exposure. Although <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span> is not contagious, it may recur because the organism that causes the disease is part of the normal skin flora.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo is contraindicated in persons who have known <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> to the active ingredient or excipients of this formulation.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-5"></a><p></p>
<h1>PRECAUTIONS</h1>
<p class="First">Severe <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reactions</span>, including <span class="product-label-link" type="condition" conceptid="441202" conceptname="Anaphylaxis">anaphylaxis</span>, have been reported during post-marketing use of NIZORAL<span class="Sup">®</span> (ketoconazole) Shampoo. If a reaction suggesting sensitivity or chemical irritation should occur, use of the medication should be discontinued.</p>
<div class="Section" data-sectionCode="34076-0">
<a name="section-5.1"></a><p></p>
<p class="First"><span class="Bold">Information for Patients:</span></p>
<p>Patients should be advised of the following:</p>
<ul>
<li>NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo may be irritating to mucous membranes of the eyes and contact with this area should be avoided.</li>
<li>The following have been reported with the use of NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo: <span class="product-label-link" type="condition" conceptid="4242607" conceptname="Hair discoloration">hair discoloration</span> and abnormal hair texture, removal of the curl from permanently waved hair, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="4010479" conceptname="Sensation of burning of skin">skin burning sensation</span> and <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span>, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">alopecia</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4280604" conceptname="Skin irritation">skin irritation</span>, <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry skin</span>, and <span class="product-label-link" type="condition" conceptid="4319310" conceptname="Application site reaction">application site reactions</span>. </li>
<li>Patients who develop <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergic reactions</span>, such as generalized <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="4089139" conceptname="Skin reaction">skin reactions</span>, severe <span class="product-label-link" type="condition" conceptid="4275722" conceptname="Swelling">swelling</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, or <span class="product-label-link" type="condition" conceptid="312437" conceptname="Dyspnea">shortness of breath</span> should discontinue NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo and contact their physician immediately.</li>
</ul>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-5.2"></a><p></p>
<h2>Carcinogenesis, Mutagenesis, Impairment of Fertility:</h2>
<p class="First">Long-term studies to assess the carcinogenic potential of NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo have not been conducted. A long-term feeding study of ketoconazole in Swiss Albino mice and in Wistar rats showed no evidence of oncogenic activity. The dominant lethal mutation test in male and female mice revealed that single oral doses of ketoconazole as high as 80 mg/kg were not genotoxic. The Ames <span class="product-label-link" type="condition" conceptid="4235289" conceptname="Salmonellosis">Salmonella</span> microsomal activator assay was also negative. </p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-5.3"></a><p></p>
<div class="Section" data-sectionCode="34077-8">
<a name="section-5.3.1"></a><p></p>
<p class="First"><span class="Bold">Pregnancy: Teratogenic effects: Pregnancy Category C:</span></p>
<p>There are no adequate and well-controlled studies in pregnant women. Ketoconazole should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. In humans, ketoconazole is not detected in plasma after chronic shampooing on the scalp.</p>
<p>Ketoconazole has been shown to be teratogenic (syndactylia and oligodactylia) in the rat when given orally in the diet at 80 mg/kg/day (a dose 10 times the maximum recommended human oral dose). However, these effects may be related to maternal toxicity, which was seen at this and higher dose levels.</p>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-5.4"></a><p></p>
<p class="First"><span class="Bold">Nursing mothers: </span> There are no adequate and well-controlled studies in nursing women. Ketoconazole is not detected in plasma after chronic shampooing on the scalp. Caution should be exercised when NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo is administered to a nursing woman.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-5.5"></a><p></p>
<p class="First"><span class="Bold">Pediatric Use: </span> Safety and effectiveness in children have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-6"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<div class="Section" data-sectionCode="42229-5">
<a name="section-6.1"></a><p></p>
<h2>Clinical Trials Experience</h2>
<p class="First">In 11 double-blind trials in 264 patients using ketoconazole 2% shampoo for the treatment of <span class="product-label-link" type="condition" conceptid="4308080" conceptname="Pityriasis simplex">dandruff</span> or <span class="product-label-link" type="condition" conceptid="137053" conceptname="Seborrheic dermatitis">seborrheic dermatitis</span>, an increase in normal <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">hair loss</span> and irritation occurred in less than 1% of patients. In three open-label safety trials in which 41 patients shampooed 4–10 times weekly for six months, the following adverse experiences each occurred once: abnormal hair texture, scalp <span class="product-label-link" type="condition" conceptid="4158333" conceptname="Pustule">pustules</span>, mild dryness of the skin, and <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>. As with other shampoos, oiliness and dryness of hair and scalp have been reported. In a double-blind, placebo-controlled trial in which patients with <span class="product-label-link" type="condition" conceptid="134870" conceptname="Pityriasis versicolor">tinea versicolor</span> were treated with either a single application of NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo (n=106), a daily application for three consecutive days (n=107), or placebo (n=105), drug-related adverse events occurred in 5 (5%), 7 (7%) and 4 (4%) of patients, respectively. The only events that occurred in more than one patient in any one of the three treatment groups were <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, <span class="product-label-link" type="condition" conceptid="4319310" conceptname="Application site reaction">application site reaction</span>, and <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry skin</span>; none of these events occurred in more than 3% of the patients in any one of the three groups.</p>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-6.2"></a><p></p>
<h2>Post-marketing Experience</h2>
<p class="First">Because these reactions are reported voluntarily from a population of uncertain size, it is not possible to reliably estimate their frequency. The following adverse drug reactions have been identified during post-marketing experience with NIZORAL<span class="Sup">®</span> (ketoconazole) Shampoo: there have been reports of <span class="product-label-link" type="condition" conceptid="4242607" conceptname="Hair discoloration">hair discoloration</span> and abnormal hair texture, <span class="product-label-link" type="condition" conceptid="4302654" conceptname="Itching">itching</span>, <span class="product-label-link" type="condition" conceptid="4010479" conceptname="Sensation of burning of skin">skin burning sensation</span>, <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">contact dermatitis</span>, <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span>, <span class="product-label-link" type="condition" conceptid="432791" conceptname="Angioedema">angioedema</span>, <span class="product-label-link" type="condition" conceptid="133280" conceptname="Alopecia">alopecia</span>, <span class="product-label-link" type="condition" conceptid="140214" conceptname="Eruption">rash</span>, <span class="product-label-link" type="condition" conceptid="139900" conceptname="Urticaria">urticaria</span>, <span class="product-label-link" type="condition" conceptid="4280604" conceptname="Skin irritation">skin irritation</span>, <span class="product-label-link" type="condition" conceptid="4039266" conceptname="Dry skin">dry skin</span>, and <span class="product-label-link" type="condition" conceptid="4319310" conceptname="Application site reaction">application site reactions</span>.</p>
</div>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-7"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo is intended for external use only. In the event of accidental ingestion, supportive and symptomatic measures should be employed. Induced <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> and gastric lavage should not be performed to avoid <span class="product-label-link" type="condition" conceptid="4239038" conceptname="Pulmonary aspiration">aspiration</span>.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-8"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">Apply the shampoo to the damp skin of the affected area and a wide margin surrounding this area. Lather, leave in place for 5 minutes, and then rinse off with water.</p>
<p>One application of the shampoo should be sufficient.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-9"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">NIZORAL<span class="Sup">®</span> (ketoconazole) 2% Shampoo is a red-orange liquid supplied in a 4-fluid ounce (120 mL) nonbreakable plastic bottle (NDC 50458-680-08).</p>
<div class="Section" data-sectionCode="44425-7">
<a name="section-9.1"></a><p></p>
<p class="First"><span class="Bold">Storage conditions:</span> Store at a temperature not above 25°C (77°F). Protect from light.</p>
</div>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-10"></a><p></p>
<p class="First">Product of Belgium</p>
<p>Manufactured by: <br>Janssen Pharmaceutica N.V. <br>Beerse, Belgium</p>
<p>Manufactured for: <br>Janssen Pharmaceuticals, Inc. <br>Titusville, NJ 08560</p>
<p>©Janssen Pharmaceuticals, Inc. 2004</p>
<p>Revised: October 2013</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-11"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 120 mL Bottle Label</h1>
<p class="First"><span class="Bold">NDC</span> 50458-680-08</p>
<p><span class="Bold">NIZORAL</span><span class="Sup">®</span><br>(ketoconazole) 2%<br><span class="Bold Italics">Shampoo</span></p>
<p><span class="Bold Italics">For topical application only.<br>Rx only.<br>4 fl. oz. (120 mL)</span></p>
<p>janssen</p>
<p>US - 987863</p>
<div class="Figure"><img alt="Principal Display Panel - 120 mL Bottle Label" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=efbc6388-90ce-11de-b92c-8b7156d89593&amp;name=nizoral-shampoo-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>NIZORAL 		
					</strong><br><span class="contentTableReg">ketoconazole shampoo</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:50458-680</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>ketoconazole</strong> (ketoconazole) </td>
<td class="formItem">ketoconazole</td>
<td class="formItem">20 mg  in 1 mL</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>COCO DIETHANOLAMIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>DISODIUM LAURETH SULFOSUCCINATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>FD&amp;C RED NO. 40</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>HYDROCHLORIC ACID</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>IMIDUREA</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>PEG-120 METHYL GLUCOSE DIOLEATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM CHLORIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>SODIUM HYDROXIDE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>SODIUM LAURETH-3 SULFATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>WATER</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Characteristics</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Color</td>
<td class="formItem">RED (red-orange) </td>
<td class="formLabel">Score</td>
<td class="formItem">    </td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Shape</td>
<td class="formItem"></td>
<td class="formLabel">Size</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<td class="formLabel">Flavor</td>
<td class="formItem"></td>
<td class="formLabel">Imprint Code</td>
<td class="formItem"></td>
</tr>
<tr class="formTableRow">
<td class="formLabel">Contains</td>
<td class="formItem">    </td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:50458-680-08</td>
<td class="formItem">120 mL in 1 BOTTLE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA019927</td>
<td class="formItem">08/31/1990</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Janssen Pharmaceuticals, Inc.
							(063137772)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Janssen Pharmaceutica NV</td>
<td class="formItem"></td>
<td class="formItem">370005019</td>
<td class="formItem">MANUFACTURE(50458-680), ANALYSIS(50458-680)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Janssen Pharmaceutica NV</td>
<td class="formItem"></td>
<td class="formItem">374747970</td>
<td class="formItem">API MANUFACTURE(50458-680)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Noramco, Inc.</td>
<td class="formItem"></td>
<td class="formItem">057234486</td>
<td class="formItem">API MANUFACTURE(50458-680)</td>
</tr>
</table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Janssen Pharmaceutical</td>
<td class="formItem"></td>
<td class="formItem">985421372</td>
<td class="formItem">API MANUFACTURE(50458-680)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 11/2013<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>be262d81-632e-4aa1-bcc4-22b9af9755b8</div>
<div>Set id: efbc6388-90ce-11de-b92c-8b7156d89593</div>
<div>Version: 9</div>
<div>Effective Time: 20131105</div>
</div>
</div> <div class="DistributorName">Janssen Pharmaceuticals, Inc.</div></p>
</body></html>
